Pneumococcal conjugate vaccine formulations
US12280107B2 · kind B2 · utility
0Cited by
5References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 15, 2023 |
| Grant date | Apr 22, 2025 |
| Priority date | — |
| Expiry date | Feb 15, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/70
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides pneumococcal conjugate vaccine formulations comprising surfactant systems incorporating polysorbate 20 or a combination of a poloxamer and a polyol.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.